As technology improves, so do our chances of improving heart failure risk. A company called Qure.ai Technologies has an AI-powered solution designed to assist doctors in both hospital and clinic settings by automating the measurement of the CTR (cardiothoracic ratio) on chest X-rays. The chest X-ray algorithm can screen for signs of heart failure, such as an enlarged cardiothoracic ratio (CTR) and fluid in the lungs, along with other indicators visible on X-rays.
Qure.ai has received FDA clearance for measuring the CTR utilizing qXR-CTR. It is the company’s 12th FDA-cleared algorithm. The chest X-ray AI solution reduces the chances of late diagnoses, under-diagnoses and even potential misdiagnoses to deliver better patient care. Heart failure is a complex, life-threatening cardiac condition often misdiagnosed due to its nonspecific symptoms. The new advancement provides hope for better diagnoses.
For more information visit https://www.qure.ai/